Multiple faces of multiple sclerosis in the era of highly efficient treatment modalities: Lymphopenia and switching treatment options challenges daily practice
Article in International Immunopharmacology (November 2023)
The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.
Lymphopenia and DMTs for relapsing forms of MS: Considerations for the treating neurologist
Article in Neurology Clinical Practice (February 2019)
&agr;4-integrin receptor desaturation and disease activity return after natalizumab cessation
Article in Neurology Neuroimmunology & Neuroinflammation (August 2017)